Secondary analysis of the phase 2 NIVAHL trial in 82 patients with classic Hodgkin lymphoma: gonadal hormone levels were stable up to 24 months after first-line nivolumab plus doxorubicin, vinblastine and dacarbazine, suggesting preserved gonadal function.
Secondary analysisn = 82
Robertz et al. Gonadal function and fertility after Hodgkin lymphoma treatment with nivolumab-AVD in the phase 2 GHSG NIVAHL trial